Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 30, 2011. The report details a specific share repurchase transaction executed in accordance with shareholder authority granted at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 300,000 Ordinary shares of 25 pence each.
- Purchase Date: November 30, 2011.
- Price Range: Highest price paid was 1,407.5 pence per share; lowest price paid was 1,361.5 pence per share.
- Treasury Holdings (Settled): 528,082,927 shares (9.48% of total issued share capital).
- Treasury Holdings (Including Unsettled): 529,382,927 shares (10.49% of current total voting rights).
- Shares in Issue (Excluding Treasury): 5,045,088,524 shares.
Material Changes
The primary material change is the reduction of outstanding shares through the purchase of 300,000 shares, increasing the proportion of shares held in Treasury. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational outlook, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (528,082,927 settled) against the company's latest capitalization table.
- Confirm the percentage of total voting rights represented by Treasury shares (10.49% including unsettled purchases).
- Check the total number of shares in issue excluding Treasury (5,045,088,524) for accurate calculation of shareholder notification thresholds under Disclosure and Transparency Rules.
- Review the price paid per share (1,361.5 to 1,407.5 pence) to assess the cost of capital return relative to market prices on November 30, 2011.